Vivos Management
Management criteria checks 3/4
Vivos' CEO is Mike Korenko, appointed in Dec 2016, has a tenure of 7.33 years. total yearly compensation is $266.39K, comprised of 88.7% salary and 11.3% bonuses, including company stock and options. directly owns 2.54% of the company’s shares, worth $1.48M. The average tenure of the management team and the board of directors is 7.3 years and 5.6 years respectively.
Key information
Mike Korenko
Chief executive officer
US$266.4k
Total compensation
| CEO salary percentage | 88.7% |
| CEO tenure | 7.3yrs |
| CEO ownership | 2.5% |
| Management average tenure | 7.3yrs |
| Board average tenure | 5.6yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$266k | US$236k | -US$3m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$261k | US$231k | -US$2m |
| Sep 30 2022 | n/a | n/a | -US$2m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | -US$3m |
| Dec 31 2021 | US$255k | US$225k | -US$3m |
| Sep 30 2021 | n/a | n/a | -US$3m |
| Jun 30 2021 | n/a | n/a | -US$3m |
| Mar 31 2021 | n/a | n/a | -US$885k |
| Dec 31 2020 | US$218k | US$120k | -US$957k |
| Sep 30 2020 | n/a | n/a | -US$1m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$705k | US$120k | -US$2m |
| Sep 30 2019 | n/a | n/a | US$25m |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | n/a | n/a | -US$7m |
| Dec 31 2018 | US$226k | US$20k | -US$8m |
| Sep 30 2018 | n/a | n/a | -US$36m |
| Jun 30 2018 | n/a | n/a | -US$11m |
| Mar 31 2018 | n/a | n/a | -US$7m |
| Dec 31 2017 | US$165k | US$165k | -US$6m |
Compensation vs Market: Mike's total compensation ($USD266.39K) is below average for companies of similar size in the US market ($USD673.68K).
Compensation vs Earnings: Mike's compensation has increased whilst the company is unprofitable.
CEO
Mike Korenko (77 yo)
7.3yrs
Tenure
US$266,391
Compensation
Dr. Michael K. Korenko, also known as Mike, Ph. D., Sc. D., serves as the Chief Executive Officer and President at Vivos Inc. (formerly known as Advanced Medical Isotope Corporation) and served as its Inte...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 7.3yrs | US$266.39k | 2.54% $ 1.5m | |
| Independent Chairman & Secretary | 18.3yrs | no data | 2.42% $ 1.4m | |
| Chief Financial Officer | 5.3yrs | no data | 0.0041% $ 2.4k | |
| Chief Technical Manager | no data | no data | no data | |
| Chief Science Officer | no data | no data | no data | |
| Chief Radio Chemist & Radiation Safety Officer | 17.3yrs | US$114.50k | no data |
7.3yrs
Average Tenure
71.5yo
Average Age
Experienced Management: RDGL's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 6.7yrs | US$266.39k | 2.54% $ 1.5m | |
| Independent Chairman & Secretary | 18.3yrs | no data | 2.42% $ 1.4m | |
| Chairman of Medical Advisory Board | 11.4yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 1.3yrs | no data | no data | |
| Chairman of Veterinary Medical Advisory Board | 4.5yrs | no data | no data | |
| Member of Veterinary Medical Advisory Board | 1.3yrs | no data | no data |
5.6yrs
Average Tenure
78yo
Average Age
Experienced Board: RDGL's board of directors are considered experienced (5.6 years average tenure).